Throughout recent years, bringing a new therapy to the market has become much more complex. Not only in terms of regulatory requirements, but equally so in terms of involving the proper stakeholders during early therapy development. Never before has the stakeholder landscape been so diverse and multifaceted, comprising not only pharma/biotech companies, clinical research organisations and hospitals, but also payors, health technology authorities, patient advocacy organisations and a broad and diverse community of key opinion leaders.
Nowadays bringing a novel therapy to the market is only one step in making market launch a success. Driving active uptake by the community is another crucial element that can make or break this launch. This can gain even more weight in the decision-making when playing in a highly competitive landscape. Hence, highly recognized authorities and top influencers in the field can leverage buy-in from the broader community and really make a difference. Especially when several therapies hit the market almost in parallel.
Because of this, having a proper and robust stakeholder engagement plan in place is very much of a necessity, rather than just a ‘nice-to-have’. A successful engagement plan should at least consist out of the following steps:
Eventually, all involved parties directly benefit from proper stakeholder engagement:
At Modis, we have expert project managers who understand the complexity and diversity of the stakeholder landscape in life science innovation. We can help set up a stakeholder engagement plan and support in stakeholder management, to help you make your innovative launch a true success!
Project Manager Life Science